Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2018 Jan 26;8(1):1675.
doi: 10.1038/s41598-018-19889-8.

Tissue Factor-bearing MPs and the risk of venous thrombosis in cancer patients: A meta-analysis

Affiliations

Tissue Factor-bearing MPs and the risk of venous thrombosis in cancer patients: A meta-analysis

Chan-Juan Cui et al. Sci Rep. .

Abstract

Cancer patients with Tissue Factor (TF)-bearing MPs have been presented association with increased risk of venous thromboembolism (VTE), but results of these studies have not been consistent. We aimed to conduct a meta-analysis to assess the relationship between TF-bearing MPs and risk of VTE in patients with cancer. PubMed, Web of Science and EMBASE Databases were systematically retrieved up to1th June 2017. Two case-control studies and four cohort studies met the entry requirements in this analysis. The summary odd ratio (OR) were estimated by a random effect model. The overall OR was 1.76 (95% CI: 1.21-2.56, I2 = 62.0%). The OR of case-control studies was 3.41 (95% CI: 1.45-8.02, I2 = 0.0%) and that of cohort studies was1.53 (95% CI: 1.05-2.24, I2 = 66.1%). The association between TF-bearing MPs and the risk of VTE in cancer patients was found in this meta-analysis. Publication bias testing and sensitivity subgroup analysis suggested that results of this meta-analysis were robustness. In conclusion, TF-bearing MPs were associated with increased risk of VTE in patients with cancer. Whereas, more well-designed studies and more comprehensive adjustments for confounders in further studies are warranted to affirm the association.

PubMed Disclaimer

Conflict of interest statement

The authors declare that they have no competing interests.

Figures

Figure 1
Figure 1
Flow chart of study identification in the meta-analysis.
Figure 2
Figure 2
Forest plot of association between TF-bearing MPs and VTE risk in cancer patients, the horizontal lines represent the study-specific OR and 95% CI, respectively. The diamond indicates the pooled results of OR and 95% CI.
Figure 3
Figure 3
Subgroup analysis of association between TF-bearing MPs and VTE risk by study design, the horizontal lines represent the study-specific OR and 95% CI, respectively. The diamond indicates the summary results of OR with its corresponding 95% CI.
Figure 4
Figure 4
Subgroup analysis of association between TF-bearing MPs and VTE risk by detection method, the horizontal lines represent the study-specific OR and 95% CI, respectively. The diamond indicates the summary results of OR with its corresponding 95% CI.
Figure 5
Figure 5
Sensitivity analysis by omitting one study each time, each small circle and dotted lines respectively represent the OR and corresponding 95% CI of the remaining studies after excluding the corresponding research.
Figure 6
Figure 6
Funnel plot for publication bias test, each point represents a separate study for the indicated association. The horizontal and vertical axis correspond to the OR and confidence limits. s.e., standard error.

Similar articles

Cited by

References

    1. Sorensen HT, Mellemkjaer L, Olsen JH, Baron JA. Prognosis of cancers associated with venous thromboembolism. N Engl J Med. 2000;343:1846–50. doi: 10.1056/NEJM200012213432504. - DOI - PubMed
    1. Blom JW, et al. Incidence of venous thrombosis in a large cohort of 66,329 cancer patients: results of a record linkage study. J Thromb Haemost. 2006;4:529–535. doi: 10.1111/j.1538-7836.2006.01804.x. - DOI - PubMed
    1. Khorana AA, Connolly GC. Assessing risk of venous thromboembolism in the patient with cancer. J Clin Oncol. 2009;27:4839–4847. doi: 10.1200/JCO.2009.22.3271. - DOI - PMC - PubMed
    1. Geddings JE, Mackman N. Tumor-derived tissue factor-positive microparticles and venous thrombosis in cancer patients. Blood. 2013;122:1873–80. doi: 10.1182/blood-2013-04-460139. - DOI - PMC - PubMed
    1. Khorana AA. Venous thromboembolism and prognosis in cancer. Thromb Res. 2010;125:490–493. doi: 10.1016/j.thromres.2009.12.023. - DOI - PMC - PubMed

Publication types